Arrowstreet Capital’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.3M | Buy |
1,289,169
+760,975
| +144% | +$12.5M | 0.01% | 839 |
|
|
2026
Q1 | $8.6M | Buy |
528,194
+160,278
| +44% | +$2.51M | ﹤0.01% | 992 |
|
|
2025
Q4 | $5.46M | Buy |
367,916
+58,014
| +19% | +$820K | ﹤0.01% | 1112 |
|
|
2025
Q3 | $3.98M | Sell |
309,902
-174,388
| -36% | -$2.32M | ﹤0.01% | 1242 |
|
|
2025
Q2 | $7.35M | Sell |
484,290
-45,874
| -9% | -$716K | 0.01% | 1009 |
|
|
2025
Q1 | $8.85M | Sell |
530,164
-214,186
| -29% | -$3.94M | 0.01% | 840 |
|
|
2024
Q4 | $14M | Sell |
744,350
-791,490
| -52% | -$15.3M | 0.01% | 716 |
|
|
2024
Q3 | $28.9M | Buy |
1,535,840
+245,888
| +19% | +$4.71M | 0.02% | 451 |
|
|
2024
Q2 | $24.4M | Sell |
1,289,952
-111,701
| -8% | -$1.91M | 0.02% | 433 |
|
|
2024
Q1 | $22.8M | Buy |
1,401,653
+219,095
| +19% | +$3.21M | 0.02% | 470 |
|
|
2023
Q4 | $15M | Buy |
1,182,558
+499,912
| +73% | +$6.31M | 0.02% | 473 |
|
|
2023
Q3 | $9.29M | Buy |
682,646
+309,542
| +83% | +$4.78M | 0.01% | 537 |
|
|
2023
Q2 | $6.41M | Buy |
373,104
+286,735
| +332% | +$4.44M | 0.01% | 587 |
|
|
2023
Q1 | $1.2M | Buy |
86,369
+51,484
| +148% | +$758K | ﹤0.01% | 1021 |
|
|
2022
Q4 | $467K | Buy |
+34,885
| New | +$451K | ﹤0.01% | 1142 |
|
|
2022
Q3 | – | Sell |
-197,807
| Closed | -$2.52M | – | 1434 |
|
|
2022
Q2 | $2.52M | Sell |
197,807
-1,630,303
| -89% | -$20.9M | ﹤0.01% | 730 |
|
|
2022
Q1 | $23.6M | Sell |
1,828,110
-1,438,764
| -44% | -$19M | 0.03% | 372 |
|
|
2021
Q4 | $51.7M | Sell |
3,266,874
-43,523
| -1% | -$743K | 0.06% | 282 |
|
|
2021
Q3 | $64.5M | Buy |
3,310,397
+848,968
| +34% | +$16.9M | 0.08% | 263 |
|
|
2021
Q2 | $56M | Buy |
2,461,429
+743,105
| +43% | +$15.4M | 0.07% | 311 |
|
|
2021
Q1 | $31.6M | Buy |
1,718,324
+234,387
| +16% | +$3.84M | 0.04% | 419 |
|
|
2020
Q4 | $22.1M | Sell |
1,483,937
-296,299
| -17% | -$3.87M | 0.03% | 556 |
|
|
2020
Q3 | $20M | Buy |
1,780,236
+370,968
| +26% | +$3.65M | 0.03% | 555 |
|
|
2020
Q2 | $11.2M | Buy |
1,409,268
+163,248
| +13% | +$1.35M | 0.02% | 731 |
|
|
2020
Q1 | $10.1M | Buy |
1,246,020
+1,081,022
| +655% | +$12.8M | 0.03% | 479 |
|
|
2019
Q4 | $2.08M | Buy |
+164,998
| New | +$1.78M | ﹤0.01% | 1130 |
|
|
2019
Q2 | – | Sell |
-354,039
| Closed | -$2.69M | – | 1668 |
|
|
2019
Q1 | $2.69M | Sell |
354,039
-72,206
| -17% | -$580K | 0.01% | 1009 |
|
|
2018
Q4 | $3.52M | Buy |
+426,245
| New | +$4.08M | 0.01% | 658 |
|
|
2018
Q3 | – | Sell |
-202,579
| Closed | -$1.98M | – | 1232 |
|
|
2018
Q2 | $1.98M | Sell |
202,579
-333,211
| -62% | -$3.27M | ﹤0.01% | 691 |
|
|
2018
Q1 | $4.98M | Buy |
+535,790
| New | +$5.1M | 0.01% | 576 |
|
|
2015
Q4 | – | Sell |
-200,661
| Closed | -$1.17M | – | 1580 |
|
|
2015
Q3 | $1.17M | Buy |
200,661
+119,717
| +148% | +$888K | 0.01% | 883 |
|
|
2015
Q2 | $707K | Buy |
+80,944
| New | +$680K | ﹤0.01% | 905 |
|
|
2015
Q1 | – | Sell |
-1,690,385
| Closed | -$13.1M | – | 1197 |
|
|
2014
Q4 | $13.1M | Sell |
1,690,385
-230,027
| -12% | -$1.68M | 0.07% | 264 |
|
|
2014
Q3 | $12.4M | Buy |
1,920,412
+1,201,102
| +167% | +$9.28M | 0.07% | 239 |
|
|
2014
Q2 | $6.05M | Buy |
719,310
+567,049
| +372% | +$4.4M | 0.03% | 385 |
|
|
2014
Q1 | $1.02M | Buy |
152,261
+89,086
| +141% | +$540K | 0.01% | 820 |
|
|
2013
Q4 | $395K | Sell |
63,175
-42,292
| -40% | -$206K | ﹤0.01% | 1016 |
|
|
2013
Q3 | $459K | Sell |
105,467
-15,980
| -13% | -$73K | ﹤0.01% | 802 |
|
|
2013
Q2 | $537K | Buy |
+121,447
| New | +$538K | ﹤0.01% | 627 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
Arrowstreet Capital's SEM Position: Q2 2026 in Review
Arrowstreet Capital increased its Select Medical (SEM) stake by 144% in Q2 2026, buying an estimated $12.5M and bringing the position to 1,289,169 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #839.
Arrowstreet Capital first reported a position in SEM in Q2 2013 and has held it in 39 quarters since. The position peaked at $64.5M in Q3 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Arrowstreet Capital held 1,289,169 shares of Select Medical worth $21.3M as of Q2 2026.
- Arrowstreet Capital bought 760,975 Select Medical shares in Q2 2026, an estimated $12.5M.
- Select Medical made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #839 holding.
- Arrowstreet Capital first reported a position in Select Medical in Q2 2013 and has held it in 39 quarters since.
- Arrowstreet Capital's Select Medical position peaked at $64.5M in Q3 2021.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.